5 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #Glycemic #Diabetes ... #DM2 #Control #Medication ... #Algorithm #Endocrinology ... #PrimaryCare #Management
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... DecisionAid #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... pharmacotherapy #table #comparison ... #management #medications ... #diabetes #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... EricsMedicalLectures/featured #diabetes ... #medications #table ... #comparison #management ... #endocrinology
Indications for therapeutic intervention of pancreatic pseudocysts.
Complicated pancreatic pseudocysts (one criterion sufficient)
 • Compression of large
Indications for ... on CT scan) • Gastric ... and vomiting • Pain ... than 6 weeks • Diameter ... #Management